551 related articles for article (PubMed ID: 17804692)
21. Post-thymic selection of peripheral CD4+ T-lymphocytes on class II major histocompatibility antigen-bearing cells.
Shen X; König R
Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):87-96. PubMed ID: 11292263
[TBL] [Abstract][Full Text] [Related]
22. Characterization of antigen processing and presentation by resting B lymphocytes.
Gosselin EJ; Tony HP; Parker DC
J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
[TBL] [Abstract][Full Text] [Related]
23. Developmental regulation of MHC class II transport in mouse dendritic cells.
Pierre P; Turley SJ; Gatti E; Hull M; Meltzer J; Mirza A; Inaba K; Steinman RM; Mellman I
Nature; 1997 Aug; 388(6644):787-92. PubMed ID: 9285592
[TBL] [Abstract][Full Text] [Related]
24. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
[TBL] [Abstract][Full Text] [Related]
25. B lymphocyte development and activation independent of MHC class II expression.
Markowitz JS; Rogers PR; Grusby MJ; Parker DC; Glimcher LH
J Immunol; 1993 Feb; 150(4):1223-33. PubMed ID: 8432977
[TBL] [Abstract][Full Text] [Related]
26. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
27. Analysis of MHC class II presentation of particulate antigens of B lymphocytes.
Vidard L; Kovacsovics-Bankowski M; Kraeft SK; Chen LB; Benacerraf B; Rock KL
J Immunol; 1996 Apr; 156(8):2809-18. PubMed ID: 8609400
[TBL] [Abstract][Full Text] [Related]
28. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
Gombos I; Detre C; Vámosi G; Matkó J
Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
[TBL] [Abstract][Full Text] [Related]
29. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
[TBL] [Abstract][Full Text] [Related]
30. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
[TBL] [Abstract][Full Text] [Related]
31. CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells.
Klein E; Koch S; Borm B; Neumann J; Herzog V; Koch N; Bieber T
Int Immunol; 2005 Apr; 17(4):477-87. PubMed ID: 15746244
[TBL] [Abstract][Full Text] [Related]
32. Invariant chain influences the immunological recognition of MHC class II molecules.
Peterson M; Miller J
Nature; 1990 May; 345(6271):172-4. PubMed ID: 1692393
[TBL] [Abstract][Full Text] [Related]
33. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.
Lang P; Stolpa JC; Freiberg BA; Crawford F; Kappler J; Kupfer A; Cambier JC
Science; 2001 Feb; 291(5508):1537-40. PubMed ID: 11222857
[TBL] [Abstract][Full Text] [Related]
34. Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer.
Inoue Y; Nakayama Y; Minagawa N; Katsuki T; Nagashima N; Matsumoto K; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
Anticancer Res; 2005; 25(5):3541-6. PubMed ID: 16101177
[TBL] [Abstract][Full Text] [Related]
35. The selective antigen-presenting cell capacity of activated B lymphocytes in HLA-II-restricted responses of CD4+ T lymphocytes.
Van Der Pouw Kraan TT; Stiekema FE; Teunissen MB; Bos JD; Kapsenberg L
Immunology; 1989 Oct; 68(2):147-53. PubMed ID: 2572541
[TBL] [Abstract][Full Text] [Related]
36. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.
Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676
[TBL] [Abstract][Full Text] [Related]
37. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
[TBL] [Abstract][Full Text] [Related]
38. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
Grant CF; Ali R; Povey S; Stockinger B
Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
[TBL] [Abstract][Full Text] [Related]
39. Mixed-haplotype MHC class II molecules select functional CD4+ T cells.
Silk JD; Schoendorf D; Bartok I; Chai JG; Gray D; Simpson E; Dyson J
Mol Immunol; 2005 Jun; 42(10):1129-39. PubMed ID: 15829303
[TBL] [Abstract][Full Text] [Related]
40. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
Patel DM; Dudek RW; Mannie MD
Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
